Drug Shortage Report for THALLIUM
Report ID | 81781 |
Drug Identification Number | Not Applicable/non applicable |
Brand name | THALLIUM |
Common or Proper name | Tl-201 Injection |
Company Name | LANTHEUS MI CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | THALLIUM CHLORIDE |
Strength(s) | 2MCI |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10mL glass vial |
ATC code | V09GX |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-03-15 |
Estimated end date | |
Actual end date | 2019-05-10 |
Shortage status | Resolved |
Updated date | 2019-05-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2X6 |
Company contact information | lmicanada@lantheus.com 1-800-811-5500 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-05-11 | English | Compare |
v6 | 2019-05-10 | French | Compare |
v5 | 2019-05-10 | English | Compare |
v4 | 2019-04-16 | French | Compare |
v3 | 2019-04-16 | English | Compare |
v2 | 2019-04-16 | English | Compare |
v1 | 2019-04-16 | English | Compare |
Showing 1 to 7 of 7